These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2315931)

  • 1. Organ-selective switching of 3-methylindole toxicity by glutathione depletion.
    Yost GS; Kuntz DJ; McGill LD
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):40-51. PubMed ID: 2315931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
    Chellman GJ; White RD; Norton RM; Bus JS
    Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology and glutathione status in 3-methylindole-treated rodents.
    Adams JD; Laegreid WW; Huijzer JC; Hayman C; Yost GS
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):323-36. PubMed ID: 3175331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glutathione status on covalent binding and pneumotoxicity of 3-methylindole in goats.
    Nocerini MR; Carlson JR; Breeze RG
    Life Sci; 1983 Jan; 32(5):449-58. PubMed ID: 6823204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of specific antibodies: utilization to predict organ- and species-selective pneumotoxicity of 3-methylindole.
    Kaster JK; Yost GS
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):324-37. PubMed ID: 9144449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats.
    Standeven AM; Wetterhahn KE
    Pharmacol Toxicol; 1991 Jun; 68(6):469-76. PubMed ID: 1891442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved use of buthionine sulfoximine to prevent cisplatin nephrotoxicity in rats.
    Mayer RD; Lee KE; Cockett AT
    J Cancer Res Clin Oncol; 1989; 115(5):418-22. PubMed ID: 2808478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T; Nakahori Y; Yamamoto K
    Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adducts of 3-methylindole and glutathione: species differences in organ-selective bioactivation.
    Nocerini MR; Carlson JR; Yost GS
    Toxicol Lett; 1985 Nov; 28(2-3):79-87. PubMed ID: 4071564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased pneumotoxicity of deuterated 3-methylindole: bioactivation requires methyl C-H bond breakage.
    Huijzer JC; Adams JD; Yost GS
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):60-8. PubMed ID: 3629592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Ito K; Nomura H; Nakanishi K
    Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse.
    Monroe DH; Eaton DL
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):118-27. PubMed ID: 3131927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine.
    Watanabe T; Sagisaka H; Arakawa S; Shibaya Y; Watanabe M; Igarashi I; Tanaka K; Totsuka S; Takasaki W; Manabe S
    J Toxicol Sci; 2003 Dec; 28(5):455-69. PubMed ID: 14746349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2'-deoxyguanosine in red blood cells.
    Misra M; Alcedo JA; Wetterhahn KE
    Carcinogenesis; 1994 Dec; 15(12):2911-7. PubMed ID: 8001255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal glutathione depletion and nephrotoxicity of cadmium-metallothionein in rats.
    Suzuki CA; Cherian MG
    Toxicol Appl Pharmacol; 1989 May; 98(3):544-52. PubMed ID: 2718180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione depletion in the guinea pig and its effect on the acute cochlear toxicity of ethacrynic acid.
    Lazenby CM; Lee SJ; Harpur ES; Gescher A
    Biochem Pharmacol; 1988 Oct; 37(19):3743-7. PubMed ID: 3178887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate.
    Gopalan-Kriczky P; Hiruma S; Lotlikar PD
    Cancer Lett; 1994 Jan; 76(1):25-30. PubMed ID: 8124663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.